Doctor profile · Federal record
Dr. Kishore Sehgal, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Specialist · Hemet, CA
- NPI 1689671034
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 45 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
301 N San Jacinto St
Hemet, CA 925433113
(951) 766-6460
fax (951) 766-6459 - Mailing address
-
40229 Donomore CT
Temecula, CA 925911611
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- October 3, 2018
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- California #A42484
- Medicaid
- CA #00A424840
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1689671034. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
353,544
Distinct HCPCS
10
Medicare allowed
$5,130,859
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 142,500 | 115 | $1 | |
J9299 |
Injection, nivolumab, 1 mg | 22,960 | 11 | $30 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 20,880 | 24 | $47 | |
J9271 |
Injection, pembrolizumab, 1 mg | 19,800 | 22 | $54 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 17,410 | 79 | $7 | |
J9264 |
Injection, paclitaxel protein-bound particles, 1 mg | 17,200 | 12 | $12 | |
J9025 |
Injection, azacitidine, 1 mg | 16,200 | 11 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 11,700 | 13 | $0 | |
J1556 |
Injection, immune globulin (bivigam), 500 mg | 9,180 | 33 | $71 | |
J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units | 8,950 | 75 | $0 |
In context: peer comparison
Among 2 peers in Hemet Hematology & Oncology Physician, average services per provider: 4,351. This provider delivers 81× the peer median.Open Payments
Industry payments received
All-time total
$3,142
Transactions
78
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $1,402.54 | |
| Janssen Biotech, INC. | 7 | $178.80 | |
| AstraZeneca Pharmaceuticals Lp | 6 | $163.10 | |
| Abbvie INC. | 6 | $136.45 | |
| Merck Sharp & Dohme LLC | 4 | $104.58 | |
| Karyopharm Therapeutics INC. | 4 | $94.63 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $89.47 | |
| Pfizer INC. | 4 | $77.21 | |
| Incyte Corporation | 4 | $76.96 | |
| Celgene Corporation | 2 | $63.82 | |
| Daiichi Sankyo INC. | 2 | $59.52 | |
| Sobi, INC | 2 | $58.54 | |
| Array Biopharma INC | 2 | $53.52 | |
| Astellas Pharma US INC | 2 | $52.90 | |
| Coherus Biosciences INC. | 2 | $45.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
721
Patients
207
Total drug cost
$31,701
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 122 | 27 | $2,611 |
| Prochlorperazine Maleate | Generic | 76 | 39 | $942 |
| Ondansetron Hcl | Generic | 68 | 36 | $914 |
| Dexamethasone | Generic | 60 | 27 | $1,388 |
| Prednisone | Generic | 58 | 20 | $380 |
| Hydroxyurea | Generic | 55 | 11 | $1,456 |
| Potassium Chloride | Generic | 52 | 21 | $488 |
| Acyclovir | Generic | 42 | 0 | $841 |
| Exemestane | Generic | 37 | 11 | $20,387 |
| Letrozole | Generic | 34 | 0 | $517 |
Frequently asked questions
What is Dr. Kishore Sehgal's medical specialty?
Dr. Kishore Sehgal practices Hematology & Oncology Physician in Hemet, CA.
Where does Dr. Kishore Sehgal practice?
Dr. Kishore Sehgal practices at 301 N San Jacinto St, Hemet, CA 925433113. Office phone: 9517666460.
What is Dr. Kishore Sehgal's NPI?
Dr. Kishore Sehgal's National Provider Identifier (NPI) is 1689671034, issued by NPPES.
Does Dr. Kishore Sehgal accept Medicare assignment?
Yes. Dr. Kishore Sehgal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kishore Sehgal commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.